Blazar

Blazar is predicting response to cancer immunotherapies.

Blazar is active in the health space based in Silicon Valley, California.

Profile

Blazar is a pioneering health company focused on predicting responses to cancer immunotherapies. Developing a software platform utilizing machine learning methods, Blazar aims to provide clinical researchers and clinicians with valuable insights for patient stratification and clinical trial recruitment. Distinguished by its integration of clinical data for decision-making and utilization of datasets specific to immune response in cancer, the Blazar platform addresses critical gaps in current approaches to onco-therapy prediction. By offering a unique solution tailored to the complexities of immunotherapies, Blazar is poised to revolutionize cancer treatment strategies and enhance patient outcomes in the field of oncology.

Its activity falls under health; the profile below is assembled from public directory data.

Its base of operations is Silicon Valley, California.

It is recorded at the Plug and Play portfolio startup stage.

Website: blazar.ai